Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Physiol Res ; 67(5): 729-740, 2018 11 14.
Article in English | MEDLINE | ID: mdl-29750886

ABSTRACT

The cis(c)-9, trans(t)-11 (c9,t11) and t10,c12 isomers of conjugated linoleic acid (CLA) have been reported as agonists of peroxisome proliferator-activated receptor (PPAR) and beneficial in lipidemia and glycemia. However, it is unclear whether CLA isomers enhance or antagonize effects of conventional drugs targeting PPAR. Male Sprague-Dawley rats were fed high fat diet (HFD) for 8 weeks and treated without or with CLA, rosiglitazone or both for 4 weeks. Oral glucose tolerance and surrogate markers of insulin resistance were not significantly different for all treatments compared to untreated normal diet (ND) or HFD group, except lipoprotein levels. The combination of CLA and rosiglitazone had suppressed levels of low and high density lipoproteins (46 % and 25 %, respectively), compared to HFD-alone. Conversely, the atherogenic co-efficient of the animals received HFD or HFD+rosiglitazone+CLA was 2-folds higher than ND, HFD+rosiglitazone or HFD+CLA. Isolated aortic rings from the combined CLA and rosiglitazone treated animals were less sensitive to isoprenaline-induced relaxation among endothelium-denuded aortas with a decreased efficacy and potency (R(max)=53+/-4.7 %; pEC50=6+/-0.2) compared to endothelium-intact aortas (R(max)=100+/-9.9 %; pEC50=7+/-0.2). Our findings illustrate that the combination of CLA and rosiglitazone precede the atherogenic state with impaired endothelium-independent vasodilatation before the onset of HFD-induced insulin resistance.


Subject(s)
Atherosclerosis/blood , Diet, High-Fat/adverse effects , Isoproterenol/pharmacology , Linoleic Acids, Conjugated/adverse effects , Rosiglitazone/adverse effects , Vasodilation/physiology , Adrenergic beta-Agonists/pharmacology , Animals , Atherosclerosis/chemically induced , Atherosclerosis/etiology , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Body Weight/physiology , Linoleic Acids, Conjugated/administration & dosage , Male , Rats , Rats, Sprague-Dawley , Rosiglitazone/administration & dosage , Vasodilation/drug effects
2.
Naunyn Schmiedebergs Arch Pharmacol ; 388(10): 1061-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26051407

ABSTRACT

The functional responses of different overnight-stored in vitro tissues are not clearly described in any animal model. The influence of overnight storage in an animal model may vary between tissue types. We employed Sprague-Dawley rat as our animal model and investigated the functional changes of rat aorta, trachea, bronchus and bladder that were used (i) immediately after surgical removal (denoted as fresh) and (ii) after storage in aerated (95% O2, 5% CO2) Krebs-Ringer bicarbonate solution at 4 °C for 24 h (denoted as stored). The aorta ring was pre-contracted with phenylephrine, and the functional response of the tissue was investigated using isoprenaline, forskolin and carbachol. Carbachol was also used to increase the tone in trachea, bronchus rings and bladder strips. A clear reduced function of endothelium, with a minor if any effect in the smooth muscle function in rat aorta was observed after overnight storage. The contractile response of overnight-stored rat airway (trachea and bronchus) and bladder smooth muscles remained unchanged. Among all tested tissues, only bronchus showed a reduced response rate (only 40% responded) after storage. In vitro rat tissues that are stored in Krebs solution at 4 °C for 24 h can still be used to investigate smooth muscle responses, however, not endothelium-mediated responses for aorta. The influence of overnight storage on different tissues from an animal model (Sprague-Dawley rat in our study) also provides an insight in maximising the use of sacrificed animals.


Subject(s)
Endothelium, Vascular/drug effects , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth/drug effects , Animals , Carbachol/pharmacology , Colforsin/pharmacology , Endothelium, Vascular/metabolism , Isoproterenol/pharmacology , Male , Models, Animal , Muscle, Smooth/metabolism , Muscle, Smooth, Vascular/metabolism , Phenylephrine/pharmacology , Rats , Rats, Sprague-Dawley , Time Factors , Tissue Preservation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...